Monitoring and Biomarker Targets During a MOTS-C Protocol A MOTS-c dosage protocol without biomarker monitoring is an incomplete intervention
************************************************************************* Thanks to many of you Ground Truth subscribers who helped put SUPER AGERS on the NYT bestseller list for 4 weeks so far
TBARS assays were performed in hippocampal homogenates from control (n = 5), IH 10 (Saline IH , n = 5), and IH 10 with concurrent administration of the superoxide anion scavenger, MnTMPYP, (MnTMPyP IH , n = 5)
The safety profile of DSIP is remarkable: 97% tolerability in clinical trials, and no lethal dose (LD50) has ever been determined in animals
The 2026 broader peptide-therapy reviews (PMID 41966639) place this compound class in the wider research-context of unapproved compounds under active investigation
Vitamin C boosts your immune system and fights oxidative stress